JBAFX
Price
$30.66
Change
+$0.15 (+0.49%)
Updated
Aug 6 closing price
Net Assets
5.95B
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

JBAFX vs RLBCX

Header iconJBAFX vs RLBCX Comparison
Open Charts JBAFX vs RLBCXBanner chart's image
JHancock Balanced R4
Price$30.66
Change+$0.15 (+0.49%)
VolumeN/A
Net Assets5.95B
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
JBAFX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JBAFX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBAFX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. JBAFX (5.95B). JBAFX pays higher dividends than RLBCX: JBAFX (1.68) vs RLBCX (1.56). JBAFX was incepted earlier than RLBCX: JBAFX (17 years) vs RLBCX (23 years). JBAFX (0.98) is less costly to investors than RLBCX (0.89). JBAFX is a more actively managed with annual turnover of: 67.00 vs. RLBCX (44.00). JBAFX has a lower initial minimum investment than RLBCX: JBAFX (0) vs RLBCX (250). JBAFX annual gain was more profitable for investors over the last year : 11.70 vs. RLBCX (11.04). JBAFX return over 5 years is better than : 41.79 vs. RLBCX (34.79).
JBAFXRLBCXJBAFX / RLBCX
Total Expense Ratio0.870.8998%
Annual Report Gross Expense Ratio0.980.89110%
Fund Existence17 years23 years-
Gain YTD7.0388.35984%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.95B253B2%
Annual Yield % from dividends1.681.56108%
Returns for 1 year11.7011.04106%
Returns for 3 years34.3629.84115%
Returns for 5 years41.7934.79120%
Returns for 10 years83.5860.65138%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE1.650.01
+0.61%
Aprea Therapeutics
CFG46.64-0.29
-0.62%
Citizens Financial Group
CMPS4.31-0.05
-1.15%
COMPASS Pathways Plc
CNTB2.07-0.06
-2.82%
Connect Biopharma Holdings Limited
LRN144.05-4.27
-2.88%
Stride